Publicação
Assessment of patients with hereditary transthyretin amyloidosis : understanding the impact of management and disease progression
| Resumo: | Timely diagnosis of hereditary variant transthyretin (ATTRv) amyloidosis is critical for appropriate treatment and optimal outcomes. Significant differences are seen between patients receiving treatment and those who are not, though disease progression may continue despite treatment in some patients. Healthcare professionals caring for patients with ATTRv amyloidosis therefore need reliable ongoing assessments to understand the continuing course of disease and make appropriate treatment choices on an individual basis. Various signs and symptoms experienced by patients may be evaluated as indicators of disease progression, though there is currently no validated score that can be used for such ongoing assessment. Recognizing this situation, a group of clinicians highly experienced in ATTR amyloidosis developed an approach to understand and define disease progression in diagnosed and treated patients with ATTRv amyloidosis. The suggested approach is based on the recognition of distinct phenotypes which may usefully inform the particular tools, tests and investigations that are most likely to be appropriate for individual patients. It is aimed at implementing appropriate and ongoing assessment of patients being treated for ATTRv amyloidosis, such that the effectiveness of management can be usefully assessed throughout the course of disease and management can be tailored according to the patient’s requirements. |
|---|---|
| Autores principais: | Conceição, isabel |
| Outros Autores: | Coelho, Teresa; Rapezzi, Claudio; Parman, Yeşim; Obici, Laura; Galán, Lucía; Rousseau, Antoine |
| Assunto: | ATTR Amyloidosis Follow-up Hereditary Monitoring Progression Transthyretin |
| Ano: | 2019 |
| País: | Portugal |
| Tipo de documento: | artigo |
| Tipo de acesso: | acesso aberto |
| Instituição associada: | Universidade de Lisboa |
| Idioma: | inglês |
| Origem: | Repositório da Universidade de Lisboa |
Registos relacionados
article Health-related quality of life in hereditary transthyretin amyloidosis polyneuropathy: a prospective, observational study
por: Inês, Mónica
Publicado em: (2020)
por: Inês, Mónica
Publicado em: (2020)
article Updated evaluation of the safety, efficacy and tolerability of Tafamidis in the treatment of hereditary transthyretin amyloid polyneuropathy
por: Falcão De Campos, Catarina
Publicado em: (2023)
por: Falcão De Campos, Catarina
Publicado em: (2023)
article World Heart Federation consensus on transthyretin amyloidosis cardiomyopathy (ATTR-CM)
por: Brito, Dulce
Publicado em: (2023)
por: Brito, Dulce
Publicado em: (2023)
article Red-flag symptom clusters in transthyretin familial amyloid polyneuropathy
por: Conceição, isabel
Publicado em: (2016)
por: Conceição, isabel
Publicado em: (2016)
article Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year update
por: Brannagan, Thomas H.
Publicado em: (2022)
por: Brannagan, Thomas H.
Publicado em: (2022)
article A phase II, open-label, extension study of long-term patisiran treatment in patients with hereditary transthyretin-mediated (hATTR) amyloidosis
por: Coelho, Teresa
Publicado em: (2020)
por: Coelho, Teresa
Publicado em: (2020)
article The sensitivity of DPD scintigraphy to detect transthyretin cardiac amyloidosis in V30M mutation depends on the phenotypic expression of the disease
por: Coutinho, Maria Conceição Azevedo
Publicado em: (2020)
por: Coutinho, Maria Conceição Azevedo
Publicado em: (2020)
article Right ventricular to pulmonary artery coupling and prognosis in transthyretin cardiac amyloidosis
por: Meucci, Maria Chiara
Publicado em: (2024)
por: Meucci, Maria Chiara
Publicado em: (2024)
article Expert consensus on the monitoring of transthyretin amyloid cardiomyopathy
por: Garcia‐Pavia, Pablo
Publicado em: (2021)
por: Garcia‐Pavia, Pablo
Publicado em: (2021)
article Management of asymptomatic gene carriers of transthyretin familial amyloid polyneuropathy
por: Schmidt, Hartmut H.‐J.
Publicado em: (2016)
por: Schmidt, Hartmut H.‐J.
Publicado em: (2016)
article Transthyretin deposition in the eye in the era of effective therapy for hereditary ATTRV30M amyloidosis
por: Buxbaum, Joel N.
Publicado em: (2019)
por: Buxbaum, Joel N.
Publicado em: (2019)
article Gait characterization and analysis of hereditary amyloidosis associated with transthyretin patients: a case series
por: Vilas-Boas, Maria do Carmo
Publicado em: (2022)
por: Vilas-Boas, Maria do Carmo
Publicado em: (2022)
article A non-invasive method based on saliva to characterize transthyretin in familial amyloidotic polyneuropathy patients using FT-ICR high-resolution MS
por: Costa, Gonçalo da
Publicado em: (2010)
por: Costa, Gonçalo da
Publicado em: (2010)
article Survival in transthyretin familial amyloid polyneuropathy : a review
por: Inês, Mónica
Publicado em: (2019)
por: Inês, Mónica
Publicado em: (2019)
article Quantification methods for 99mTc-labelled disphosphonates uptake in cardiac amyloidosis
por: Ferreira, José Manuel Belo
Publicado em: (2025)
por: Ferreira, José Manuel Belo
Publicado em: (2025)
newspaper To silence or to stabilize: that is the question
por: Augusto, João Bicho
Publicado em: (2025)
por: Augusto, João Bicho
Publicado em: (2025)
article Novel approaches to diagnosis and management of hereditary transthyretin amyloidosis
por: Carroll, Antonia
Publicado em: (2022)
por: Carroll, Antonia
Publicado em: (2022)
article Identification of hereditary cancer in the general population: development and validation of a screening questionnaire for obtaining the family history of cancer
por: Campacci, Natália
Publicado em: (2017)
por: Campacci, Natália
Publicado em: (2017)
article Remote versus in-office monitoring for implantable cardioverter defibrillators: results from a randomized pragmatic controlled study in Portugal
por: Oliveira, Mário
Publicado em: (2022)
por: Oliveira, Mário
Publicado em: (2022)
article Transthyretin is involved in depression-like behaviour and exploratory activity
por: Sousa, João Carlos
Publicado em: (2004)
por: Sousa, João Carlos
Publicado em: (2004)
article Erythrocyte membrane protein destabilization versus clinical outcome in 160 portuguese hereditary spherocytosis patients
por: Rocha, Susana
Publicado em: (2010)
por: Rocha, Susana
Publicado em: (2010)
article Transthyretin as a thyroid hormone carrier: function revisited
por: Palha, Joana Almeida
Publicado em: (2002)
por: Palha, Joana Almeida
Publicado em: (2002)
school Myocardtis: long-term follow-up and management
por: Cardoso, Margarida dos Santos
Publicado em: (2024)
por: Cardoso, Margarida dos Santos
Publicado em: (2024)
image Hopelessness a predictor of spiritual distress nursing diagnosis in cancer patients: a follow-up study
por: Martins, Helga
Publicado em: (2023)
por: Martins, Helga
Publicado em: (2023)
article Omnichannel adoption in health information systems for patient follow-up
por: Moreira, Ailton
Publicado em: (2023)
por: Moreira, Ailton
Publicado em: (2023)
school Envolvimento do sistema nervoso central em “Hereditary Neuropathy with liability to Pressure Palsies”
por: Lima, Diogo Afonso Figueiredo de
Publicado em: (2020)
por: Lima, Diogo Afonso Figueiredo de
Publicado em: (2020)
school Vascular alterations in Alzheimer’s Disease - role of Aß peptide and Transthyretin?
por: Gião, Tiago André Braga
Publicado em: (2020)
por: Gião, Tiago André Braga
Publicado em: (2020)
school Hereditary angioedema and polycystic ovary syndrome : a literature review and case report
por: Morgado, Raquel Ramalho Ortigão de Figueiredo
Publicado em: (2023)
por: Morgado, Raquel Ramalho Ortigão de Figueiredo
Publicado em: (2023)
article Transthyretin and Alzheimer's disease: where in the brain?
por: Sousa, João Carlos
Publicado em: (2007)
por: Sousa, João Carlos
Publicado em: (2007)
article Defective flow-migration coupling causes arteriovenous malformations in hereditary hemorrhagic telangiectasia
por: Park, Hyojin
Publicado em: (2021)
por: Park, Hyojin
Publicado em: (2021)
article Loss to follow-up in registries of rheumatic patients treated with biologics : a potential information bias in assessing pharmacovigilance and efficacy outcomes
por: Valido, Ana
Publicado em: (2019)
por: Valido, Ana
Publicado em: (2019)
article Early diagnostic tools in hereditary amyloidosis related to transthyretin hATTR V30M autonomic neuropathy
por: Falcão De Campos, Catarina
Publicado em: (2019)
por: Falcão De Campos, Catarina
Publicado em: (2019)
article Protocol-based follow-up program for heart failure patients : impact on prognosis and quality of life
por: Agostinho, João R.
Publicado em: (2019)
por: Agostinho, João R.
Publicado em: (2019)
article Neuropsychological Predictors of long-term (10 Years) Mild Cognitive Impairment Stability
por: Alves, Luísa
Publicado em: (2018)
por: Alves, Luísa
Publicado em: (2018)
article Covariates of high-risk human papillomavirus (HPV) infections are distinct for incident CIN1, CIN2 and CIN3 as disclosed by competing-risks regression models
por: Syrjänen, K.
Publicado em: (2012)
por: Syrjänen, K.
Publicado em: (2012)
article Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline
por: Sessa, C.
Publicado em: (2023)
por: Sessa, C.
Publicado em: (2023)
article Transthyretin proteins regulate angiogenesis by conferring different molecular identities to endothelial cells
por: Nunes, Raquel J.
Publicado em: (2013)
por: Nunes, Raquel J.
Publicado em: (2013)
article Nonalcoholic steatohepatitis : a long-term follow-up study : comparison with alcoholic hepatitis in ambulatory and hospitalized patients
por: Cortez-Pinto, Helena
Publicado em: (2003)
por: Cortez-Pinto, Helena
Publicado em: (2003)
article Monitorização à distância versus seguimento convencional presencial em portadores de dispositivos cardíacos implantados : racional e desenho do estudo PORTLink (PORTuguese Research on Telemonitoring with CareLink)
por: Oliveira, Mário
Publicado em: (2013)
por: Oliveira, Mário
Publicado em: (2013)
school A importância do follow-up na auditoria interna em Portugal
por: Madeira, André Aldo Dias
Publicado em: (2013)
por: Madeira, André Aldo Dias
Publicado em: (2013)
Registos relacionados
-
article Health-related quality of life in hereditary transthyretin amyloidosis polyneuropathy: a prospective, observational study
por: Inês, Mónica
Publicado em: (2020) -
article Updated evaluation of the safety, efficacy and tolerability of Tafamidis in the treatment of hereditary transthyretin amyloid polyneuropathy
por: Falcão De Campos, Catarina
Publicado em: (2023) -
article World Heart Federation consensus on transthyretin amyloidosis cardiomyopathy (ATTR-CM)
por: Brito, Dulce
Publicado em: (2023) -
article Red-flag symptom clusters in transthyretin familial amyloid polyneuropathy
por: Conceição, isabel
Publicado em: (2016) -
article Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year update
por: Brannagan, Thomas H.
Publicado em: (2022)